Brandi L Vollmer

4PUBLICATIONS
9CO-AUTHORS
Rheumatology and arthritisImmunogenetics (incl. genetic immunology)Regenerative medicine (incl. stem cells)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 13, 2025
Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter, retrospective observational experience.

Brandi L Vollmer, Tammy Hoyt, Timothy W West

|Aug 09, 2020
Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.

Brandi L Vollmer, Kavita Nair, Stefan Sillau

|Aug 09, 2020
Serious safety events in rituximab-treated multiple sclerosis and related disorders.

Brandi L Vollmer, Asya I Wallach, John R Corboy

Pageof 1